Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
American Journal of Physiology. Heart and Circulatory Physiology|October 6, 2009
EDHF function in the ductus arteriosus: evidence against involvement of epoxyeicosatrienoic acids and 12S-hydroxyeicosatetraenoic acidBarbara Baragatti, Michal Laniado Schwartzman, Debora Angeloni, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 16, 2011
Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligandRafael Ochoa-Sanchez, Stefano Comai, Baptiste Lacoste, et al.
Genes, Chromosomes & Cancer|April 12, 2006
Analysis of a new homozygous deletion in the tumor suppressor region at 3p12.3 reveals two novel intronic noncoding RNA genesDebora Angeloni, Arja ter Elst, Ming Hui Wei, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 21, 2019
MICAL2 is expressed in cancer associated neo-angiogenic capillary endothelia and it is required for endothelial cell viability, motility and VEGF responseIvana Barravecchia, Sara Mariotti, Angela Pucci, et al.
Cell Death & Disease|August 20, 2020
MICAL2 is essential for myogenic lineage commitmentNefele Giarratana, Filippo Conti, Rita La Rovere, et al.
Oncotarget|December 23, 2015
MICAL2 is a novel human cancer gene controlling mesenchymal to epithelial transition involved in cancer growth and invasionSara Mariotti, Ivana Barravecchia, Carla Vindigni, et al.
Cellular and Molecular Life Sciences : CMLS|December 22, 2021
Microgravity and space radiation inhibit autophagy in human capillary endothelial cells, through either opposite or synergistic effects on specific molecular pathwaysIvana Barravecchia, Chiara De Cesari, Mattia Forcato, et al.
Pain|January 20, 2015
Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathwaysMartha Lopez-Canul, Enza Palazzo, Sergio Dominguez-Lopez, et al.
Plos One|August 30, 2008
HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitroFuli Wang, Elvira V Grigorieva, Jingfeng Li, et al.
Molecules (Basel, Switzerland)|December 24, 2021
Enriching the Arsenal of Pharmacological Tools against MICAL2Ivana Barravecchia, Elisabetta Barresi, Camilla Russo, et al.
Pageof 5